A federal judge reduced a $9 billion jury verdict in the first federal trial over diabetes drug Actos by 99 percent, but what’s left still would rank among the largest punitive damages awards on record when compared to compensatory damages in the case.
U.S. District Judge Rebecca Doherty of the Western District of Louisiana on Monday dropped the jury’s award to $27.6 million against Takeda Pharmaceuticals USA Inc. and $9.2 million against Eli Lilly and Co., while rejecting a motion for a new trial on punitive damages. Both defendants had argued the original award violated their due-process rights under the Fourteenth Amendment. They have vowed to appeal even the reduced award.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
